Léon Bérard Center

Lyon 69373

0 studies enrolling now · 1 studies all time

What they study most

CML, Refractory, CML, Relapsed

Studies at this site

• Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments — TEMPORARILY_NOT_AVAILABLE